Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Harrow, Inc. announced a 60% sequential and 11% year-over-year revenue increase to $70.7 million in Q2 2026. The company reiterated full-year revenue guidance of $350-$365 million and adjusted EBITDA between $80-$100 million. Key products VEVYE, IHEEZO, and TRIESENCE showed significant unit demand growth. Harrow also launched BYOOVIZ, a retinal bio…
Ticketplus Ltd., a Chile-based technology platform specializing in live entertainment ticketing across Latin America, successfully closed its initial public offering of 1,875,000 shares priced at $8.00 each, raising $15 million before expenses. The company's shares started trading on the NYSE American on August 7, 2026, under the ticker TP. Ticketp…
Vera Therapeutics announced FDA accelerated approval for TRUTAKNA, the first and only therapy targeting BAFF and APRIL to treat adults with primary IgA nephropathy (IgAN) at risk for disease progression. The company has launched commercial U.S. sales, aligned with the FDA to pursue potential full approval pending ORIGIN 3 trial results expected in …
Playboy, Inc. announced solid second quarter 2026 financial results, highlighted by 11% revenue growth to $31.2 million driven by Honey Birdette's 18.2% sales increase, a return to net income of $0.2 million compared to a prior year loss, and a doubling of adjusted EBITDA to $7.0 million. The company also initiated a significant share repurchase an…
Tactile Systems Technology, Inc. reported its Q2 2026 financial results showing a 9% year-over-year revenue increase to $85.7 million and net income more than doubling to $7.8 million. The company expanded gross margins to 76%, launched new products including the next-generation AffloVest system, and entered an exclusive U.S. distribution deal for …
CeriBell, Inc., a US-based medical technology company specializing in neurological diagnostic tools, reported a 33% increase in total revenue for Q2 2026 compared to Q2 2025, driven by growth in new and existing accounts. The company achieved a 92% gross margin, secured multiple FDA 510(k) clearances for new algorithms and hardware, and obtained Ne…
Alico, Inc. announced its Q3 2026 financial results showing a net income of $2.1 million, a substantial improvement from a net loss in the prior year quarter, driven by its ongoing strategic transformation shifting focus from citrus production to land leasing, sales, and development. The company signed a new agricultural lease for 3,280 acres with …
Gaia, Inc. reported a 5% decline in Q2 2026 revenue to $23.3 million, impacted by a strategic focus on acquiring higher-quality, direct members and reduced reliance on lower ARPU regions. Despite decreased revenue and increased marketing costs leading to a net loss of $3.0 million, the company is optimistic about long-term growth driven by new AI-p…
PennantPark Floating Rate Capital Ltd. announced its financial results for the third quarter ended June 30, 2026. The company reported net investment income of $25.9 million ($0.26 per share), a slight increase from the prior year quarter, but a 2.0% decrease in net asset value per share to $10.26. The investment portfolio totaled $2.5 billion, pri…
TTEC Holdings, Inc. announced its Q2 2026 financial results, highlighting underperformance in the Engage segment with lower revenue and profit margins compared to prior year, while the Digital segment remains on track with revenue and profitability targets. Management is exploring strategic alternatives for the TTEC Digital segment to maximize shar…
Life360 announced its Q2 2026 financial results showcasing record revenue of $159 million, up 38% year-over-year, driven by growth in subscriptions and advertising. The company achieved its highest-paying circle net additions (185,000) and surpassed 100 million monthly active users globally. Adjusted EBITDA increased 53% year-over-year to $31.1 mil…
TELA Bio, a medical technology company specializing in soft-tissue reconstruction, announced a 4% decline in Q2 2026 revenue to $19.3 million, impacted by decreased OviTex PRS unit volumes and price/mix headwinds, despite growth in international sales. The company appointed Heather Getz as CEO in August 2026. Management cited competitive challenges…
Red Violet, Inc. announced robust financial results for Q2 2026, highlighted by 23% revenue growth to $26.7 million, 85% net income increase to $5.0 million, and record customer additions to its identity intelligence platform. The company completed a financing round raising $109 million, boosting cash reserves to $50 million, and expressed confiden…
Varonis Systems, Inc., a leader in data and AI security, announced it will participate and present at the Citi 2026 Global TMT Conference in New York on September 9. The presentation will be webcast live, providing investors access to insights on Varonis' business and solutions.
Enphase Energy's Board of Directors unanimously voted to retain Benjamin Kortlang following the 2026 annual meeting vote, reaffirming his value to the board due to his expertise and commitment. The company also appointed Shanker Trivedi to the Board, assigned Joseph Malchow as Chair of the Nominating and Corporate Governance Committee, and announce…
Alamar Biosciences reported an 82% increase in total revenue for Q2 2026 to $29.4 million, driven by growth in instrument placements and consumable sales. The company launched new multiplexed blood-based immunoassays for neurodegenerative disease and immune profiling, expanded strategic partnerships, and provided full-year revenue guidance of $116–…
PennantPark Investment Corporation released its financial results for the third quarter ended June 30, 2026. The company reported a net asset value per share decrease of 2.5% to $6.56, net investment income of $0.14 per share, and declared total distributions of $0.24 per share. The firm highlighted a healthy credit quality and ongoing strategic po…
EverQuote announces an exclusive commercial partnership and a strategic minority equity investment in Waniwani to integrate agentic AI technologies into their growth solutions for property and casualty insurance providers. This collaboration aims to improve discoverability, engagement, and compliance for P&C carriers and agents across emerging AI c…
Bionano Genomics reported a 21% revenue increase to $8.2 million in Q2 2026, driven by a 31% surge in consumables sales and expanding clinical adoption of its optical genome mapping (OGM) technology. The company completed retirement of its secured convertible debentures, simplifying its financial profile. Key scientific publications and returning o…
Natural Gas Services Group, Inc. (NYSE: NGS) reported a 24.9% year-over-year increase in rental revenue to $49.4 million for Q2 2026, with adjusted EBITDA rising 27.4% to $25.1 million. The company completed the acquisition of Flatrock Compression Holdings, adding significant horsepower to its rental fleet and advancing its electric motor drive str…
Fluent, Inc. announced its second quarter 2026 financial results, highlighting an 8% increase in quarterly revenue to $48.4 million and significant growth in its Commerce Media Solutions segment, which saw revenue grow 90% to $30.5 million and now accounts for 63% of total revenue. The company continues to shift focus towards Commerce Media Solutio…
HF Foods Group Inc. reported a 2.8% increase in net revenue to $323.8 million in Q2 2026, driven by volume growth and pricing improvements, marking the highest quarterly revenue in company history. GAAP net income surged 413.9% to $2.6 million, helped by tariff refunds and other income. Adjusted EBITDA slightly declined by 2%. The company announced…
Metagenomi Therapeutics disclosed its second quarter 2026 financial results and business updates, highlighting ongoing progress toward submitting the investigational new drug (IND) application for its lead genome editing program MGX-001 aimed at treating hemophilia A. The company maintains a strong cash position of $120.7 million to support operati…
Fractyl Health announced robust one-year data from its REMAIN-1 and REVEAL-1 cohorts showing durable, drug-free weight maintenance after a single Revita procedure, significantly outperforming sham controls. The company reaffirmed its 2026 milestones including pivotal trial data readout in Q4 and potential FDA De Novo submission. Financial results s…
Annexon, Inc., a Nasdaq-listed biopharmaceutical company focused on targeted immunotherapies for neuroinflammatory diseases, announced the appointment of Dr. Mark S. Blumenkranz to its board of directors. Dr. Blumenkranz is a renowned retinal specialist and experienced biotech entrepreneur whose expertise is expected to support the commercializatio…
